These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
940 related items for PubMed ID: 24998123
1. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR. Sarno G, Lagerqvist B, Nilsson J, Frobert O, Hambraeus K, Varenhorst C, Jensen UJ, Tödt T, Götberg M, James SK. J Am Coll Cardiol; 2014 Jul 08; 64(1):16-24. PubMed ID: 24998123 [Abstract] [Full Text] [Related]
2. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. Sabaté M, Räber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iñiguez A, Tüller D, Serra A, Baumbach A, von Birgelen C, Hernandez-Antolin R, Roffi M, Mainar V, Valgimigli M, Serruys PW, Jüni P, Windecker S. JACC Cardiovasc Interv; 2014 Jan 08; 7(1):55-63. PubMed ID: 24332419 [Abstract] [Full Text] [Related]
3. New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safety. Garg A, Brodie BR, Stuckey TD, Garberich RF, Tobbia P, Hansen C, Kissling G, Kadakia H, Lips D, Henry TD. Catheter Cardiovasc Interv; 2014 Nov 15; 84(6):955-62. PubMed ID: 24174334 [Abstract] [Full Text] [Related]
4. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction). Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S. JACC Cardiovasc Interv; 2013 Jun 15; 6(6):548-53. PubMed ID: 23683734 [Abstract] [Full Text] [Related]
5. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A. JACC Cardiovasc Interv; 2013 Dec 15; 6(12):1267-74. PubMed ID: 24355117 [Abstract] [Full Text] [Related]
6. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ. JACC Cardiovasc Interv; 2011 Jan 15; 4(1):24-9. PubMed ID: 21251625 [Abstract] [Full Text] [Related]
8. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S. JACC Cardiovasc Interv; 2013 Aug 15; 6(8):777-89. PubMed ID: 23968698 [Abstract] [Full Text] [Related]
13. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G. Circulation; 2009 Sep 15; 120(11):964-72. PubMed ID: 19720939 [Abstract] [Full Text] [Related]
14. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM, Stella PR. J Am Coll Cardiol; 2012 Jun 19; 59(25):2327-37. PubMed ID: 22503057 [Abstract] [Full Text] [Related]
15. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial. Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW. JACC Cardiovasc Interv; 2014 Jan 19; 7(1):64-71. PubMed ID: 24332423 [Abstract] [Full Text] [Related]
16. Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents. Varenhorst C, Lindholm M, Sarno G, Olivecrona G, Jensen U, Nilsson J, Carlsson J, James S, Lagerqvist B. Clin Res Cardiol; 2018 Sep 19; 107(9):816-823. PubMed ID: 29667015 [Abstract] [Full Text] [Related]
17. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials. Alsidawi S, Effat M, Rahman S, Abdallah M, Leesar M. Cardiovasc Ther; 2015 Dec 19; 33(6):360-6. PubMed ID: 26363283 [Abstract] [Full Text] [Related]
18. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction. Hannan EL, Racz M, Walford G, Holmes DR, Jones RH, Sharma S, Katz S, King SB. JACC Cardiovasc Interv; 2008 Apr 19; 1(2):129-35. PubMed ID: 19463290 [Abstract] [Full Text] [Related]
19. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up. Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M. Chin Med J (Engl); 2012 Aug 19; 125(16):2803-6. PubMed ID: 22932070 [Abstract] [Full Text] [Related]
20. Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred? Giglioli C, Cecchi E, Vladi L, Stolcova M, Valente S, Meucci F, Baldereschi GJ, Chiostri M, Romano SM, Gensini GF, Barchielli A, Balzi D. J Cardiol; 2014 Apr 19; 63(4):296-301. PubMed ID: 24365386 [Abstract] [Full Text] [Related] Page: [Next] [New Search]